文献速递老年与多病共存慢病管理

法国全科医生对老年患者苯二氮䓬类及Z类药物处方全国队列研究

Prescription of benzodiazepines and Z-drugs among older patients in primary care: a French, national, cohort study.
PubMed 文献 · Fam Pract · 2024-01-01

该研究分析2000至2010年117名法国全科医生记录的门诊数据,评估65岁及以上患者就诊中苯二氮䓬类/Z类药物(BZD/ZD)处方比例及医生相关预测因素。结果显示中位处方比例为21.8%(95%CI 18.1-26.1),过度处方与患者慢性病数量多及每次就诊处方药数多独立相关,而与医生社会人口学或执业特征无关。

要点

  • 65岁以上患者全科就诊中约22%导致BZD/ZD处方,医生间范围5%-34.1%。
  • 慢性病数量多(OR 2.10)和每次就诊处方药数多(OR 5.29)与BZD/ZD过度处方独立相关。
  • 未发现医生社会人口学或执业相关特征与BZD/ZD过度处方相关。

核心结论

  • BZD/ZD过度处方与患者慢性病负担重和每次就诊处方药数多独立相关,而与医生社会人口学或执业特征无关。
  • 需要针对性措施帮助全科医生限制对多病共存和多重用药老年患者的BZD/ZD处方。

研究设计与样本

  • 法国全国性队列研究,分析2000至2010年117名全科医生前瞻性记录的会诊数据。
  • 纳入医生平均年龄47.4岁(标准差7.1),87.9%为男性。
  • 采用逻辑回归模型寻找与BZD/ZD过度处方(定义为高于中位处方率)相关的因素。

主要发现

  • 65岁及以上患者会诊导致BZD/ZD处方的中位比例为21.8%(95%CI 18.1-26.1),各医生范围5%-34.1%。
  • 多变量分析中,慢性病数量更多(OR 2.10,95%CI 1.22-3.64)与BZD/ZD过度处方独立相关。
  • 每次会诊处方药数更多(OR 5.29,95%CI 2.72-10.28)与BZD/ZD过度处方独立相关。
  • 研究参与时间较短与BZD/ZD过度处方独立相关。
  • 未发现医生社会人口学或执业相关特征与BZD/ZD过度处方相关。

关键数值与推荐

  • BZD/ZD过度处方定义为处方率高于中位数。
  • 65岁及以上患者会诊导致BZD/ZD处方的中位比例为21.8%(95%CI 18.1-26.1)。

临床怎么用

  • 对多病共存和多重用药的老年患者应特别关注BZD/ZD处方合理性。
  • 可针对慢性病负担重和处方药数多的就诊场景开展针对性干预以减少BZD/ZD过度处方。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In France, general practitioners (GPs) prescribe benzodiazepines and Z-drugs (BZD/ZDs) widely, and especially to older adults. Several characteristics of patients and/or GPs linked to BZD/ZD overprescription have been described in the general population but not among older patients in primary care. OBJECTIVES: To estimate the proportion of GP consultations by patients aged 65 and over that resulted in a BZD/ZD prescription, and determine whether any GP-related factors predicted BZD/ZD overprescription in this setting. METHODS: We analyzed sociodemographic and practice-related GP characteristics, and aggregated data on consultations recorded prospectively by 117 GPs in a database between 2000 and 2010. Next, we used logistic regression models to look for factors potentially associated with BZD/ZD overprescription (defined as an above-median prescription rate). RESULTS: The GPs' mean age at inclusion was 47.4 (7.1), and 87.9% were male. During the study period, the median (95% confidence interval) proportion of consultations with patients aged 65 and over resulting in a BZD/ZD prescription was 21.8% (18.1-26.1) (range per GP: 5-34.1%). In a multivariable analysis, a greater number of chronic disease (OR [95% CI] = 2.10 [1.22-3.64]), a greater number of drugs prescribed per consultation (5.29 [2.72-10.28]), and shorter study participation were independently associated with BZD/ZD overprescription. CONCLUSIONS: BZD/ZD overprescription was associated with a greater chronic disease burden and the number of drugs prescribed per consultation but not with any sociodemographic or practice-related GP characteristics. Targeted actions are needed to help GPs limit their prescription of BZD/ZDs to older patients with multiple comorbidities and polypharmacy. In France, general practitioners (GPs) prescribe benzodiazepines and Z-drugs (BZD/ZDs) widely, and especially to older adults. Even though BZD/ZDs may not have a favorable risk–benefit ratio in older patients, we lack data on GP-related factors that might influence BZD/ZD overprescription in our population. The objectives of the present study were to (i) estimate the proportion of GP consultations by patients aged 65 and over that resulted in a BZD/ZD prescription and (ii) identify GP-related factors that were predictive of overprescription. To achieve this goal, we analyzed consultation notes registered by 117 GPs in a database curated by the French Society of General Practice between 2000 and 2010. About 22% of consultations by patients aged 65 and over resulted in a BZD/ZD prescription. With regard to the GPs, we did not find any sociodemographic or practice-related characteristics associated with overprescription. A greater chronic disease burden and the number of drug prescriptions (other than BZD/ZDs) per consultation was independently associated with overprescription. Targeted actions are therefore needed to help GPs limit their prescription of BZD/ZDs in older patients with multimorbidity and polypharmacy.

来源:Fam Pract,查看原文。版权归原作者所有。

引用

  1. Yana J, Moscova L, Le Breton J, et al. Prescription of benzodiazepines and Z-drugs among older patients in primary care: a French, national, cohort study. Fam Pract. 2024. PMID: 36308516. doi:10.1093/fampra/cmac114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。